Burning Rock Biotech (Burning Rock Biotech) Total Assets : $136.77 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Total Assets?

Burning Rock Biotech's Total Assets for the quarter that ended in Mar. 2024 was $136.77 Mil.

During the past 12 months, Burning Rock Biotech's average Total Assets Growth Rate was -36.80% per year. During the past 3 years, the average Total Assets Growth Rate was -1.40% per year. During the past 5 years, the average Total Assets Growth Rate was 14.20% per year.

During the past 7 years, Burning Rock Biotech's highest 3-Year average Total Assets Growth Rate was 51.70%. The lowest was -1.40%. And the median was 16.00%.

Total Assets is connected with ROA %. Burning Rock Biotech's annualized ROA % for the quarter that ended in Mar. 2024 was -47.81%. Total Assets is also linked to Revenue through Asset Turnover. Burning Rock Biotech's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.

Burning Rock Biotech Total Assets Historical Data

The historical data trend for Burning Rock Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Total Assets Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

120.84

407.23

357.75

227.70

145.65

Burning Rock Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															205.69	185.82	159.87	145.65	136.77

Burning Rock Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Burning Rock Biotech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	107.617	+	38.037
	=	145.65

Burning Rock Biotech's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	99.539	+	37.228
	=	136.77

Burning Rock Biotech (NAS:BNR) Total Assets Explanation

Total Assets is connected with ROA %.

Burning Rock Biotech's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-67.512	/	( (145.654	+	136.767)	/ 2 )
	=	-67.512	/	141.2105
	=	-47.81 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Burning Rock Biotech's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	17.444	/	( (145.654	+	136.767)	/ 2 )
=	17.444	/	141.2105
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Burning Rock Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.